Skip to content

Relationship between polycystic ovary syndrome and periodontal health, as well as pregnacy of PCOS patients

Relationship between polycystic ovary syndrome and periodontal health, as well as pregnacy of PCOS patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055948
Enrollment
Unknown
Registered
2022-01-28
Start date
2022-02-09
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

Periodontal Disease Group:None
Oral health Group:None

Sponsors

Shenzhen Maternity and Child Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 34 Years

Inclusion criteria

Inclusion criteria: 1. Non-pregnant Chinese women of reproductive age (20-34 years old) who were diagnosed with PCOS in the department of gynecology of our hospital and planned to get pregnant within one year; 2. Do not smoke or drink alcohol; 3. No periodontal treatment within 12 months; 4. Healthy except for oral and obstetric conditions, without systemic diseases (see exclusion criteria); 5. No antibiotics for at least the last three months.

Exclusion criteria

Exclusion criteria: 1. Those who took antibiotics within 3 months; 2. Received professional periodontal treatment (except for supringival plaque removal) within 12 months; 3. Not in good general health (other systemic diseases such as diabetes, cardiovascular disease, cancer, infectious diseases such as AIDS, hepatitis B, syphilis, rheumatic immune system diseases, etc.) before being diagnosed with PCOS; 4. After diagnosis of PCOS, the patient had other systemic complications in addition to metabolic complications; 5. Those who have received assisted reproductive technology; 6. Unwilling to participate in the study; 7. Continuous use of immunosuppressants, bisphosphonates for osteoporosis, or steroids and other hormones and immune-related drugs.

Design outcomes

Primary

MeasureTime frame
PCOS and related treatments;Periodontal status;Sex hormones;Lipid levels;fasting insulin;Fasting plasma glucose;Early pregnancy;

Secondary

MeasureTime frame
Demographic characteristics;Lifestyles;History of gestation;Psychological health;cytokines and chemokines;Follicular development;

Countries

China

Contacts

Public ContactYao Jilong

Shenzhen Maternity and Child Healthcare Hospital

yaojilong369@163.com+86 13823556088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026